Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Fifty-plus years of unbroken dividend raises sounds like a floor, but not every Dividend King deserves a permanent seat in your portfolio right now. Five do, and one of them is actually trading at a discount that long-term income investors rarely get handed.
Personal care products provider Kimberly-Clark Corporation (NYSE:KMB)’s shares are down by 17% over the past year and are up by 9% year-to-date. It is currently undergoing a major transformation through acquiring Kenvue. Cramer has discussed Kimberly-Clark Corporation (NYSE:KMB)’s acquisition several times and linked its performance with consumer goods giant Procter & Gamble. In his morning […]
Rolling $880,000 into a self-directed IRA sounds like a clean break from the 9-to-5, but generating $5,200 a month from that balance forces a choice between safety and survival that most retirement calculators never show you.
Procter & Gamble isn't a flashy company, but its dividend will appeal to investors looking for a payout they can count on.
These stocks have terrific track records for dividend growth, and they're likely to continue raising their payouts for the foreseeable future.
Procter & Gamble (PG) has just updated investors with full year 2027 guidance, new quarterly earnings expectations, and fresh details on capital returns, including dividends and share buybacks, all released alongside its latest annual results. See our latest analysis for Procter & Gamble. At a share price of $146.44, Procter & Gamble has seen a 3.28% year to date share price return, while the 1 year total shareholder return is down 2.73%. This signals momentum that is still relatively muted...
Five Dividend Kings just posted blockbuster second-quarter results in a market that rewards almost nothing, and one of them happens to be Warren Buffett's favorite long-term hold. Defensive income investors take note: bargains this reliable rarely show up in a frothy summer market.
Procter & Gamble has one of the longest dividend increase streaks of any American company, but it's not inexpensive to wring $10,000 in year payouts from this stock.
Pulling $54,000 a year from a $950,000 rollover IRA sounds like a math problem, but the real trap is hidden in the yield tier you choose and what it quietly does to your principal over time.
There are stocks you own for growth. There are stocks you own for income. And then there are the rare ones where a business that appeared to be doing the slow, reliable work of a dividend compounder suddenly shows you something you were not expecting. Procter and Gamble has done exactly that with ...
Four Dividend Aristocrats were flagged as stealth growth plays a year ago, and the results cut sharply in two directions. See which names delivered and which stumbled, plus three fresh picks where the dividend coverage story is quietly getting stronger.
While the rest of the market chased AI headlines and flinched at every tariff rumor, three famously unglamorous stocks kept raising their dividends and quietly compounding wealth. Here is why August may be the right moment to pay attention.
These blue-chip consumer companies -- Procter & Gamble, McDonald's, and Coca-Cola -- offer reliable, growing dividends backed by resilient businesses and strong cash flow.
This dividend royalty keeps proving that steady execution, smart innovation, and shareholder-friendly capital allocation are a winning long-term formula.
This consumer staples Dividend King is down nearly 20% since its 2024 high despite its industry-leading business.
Procter & Gamble (NYSE:PG) is buying its way into wellness. On August 4, L Catterton announced it had signed a definitive agreement to sell Thorne, a science-backed health and wellness brand, to Procter & Gamble for $3.8 billion in cash. The deal lands a day after an August 3 analysis flagged a fiscal 2027 earnings […]
Procter & Gamble just logged its 70th consecutive dividend increase, yet Wall Street has turned skeptical, pointing to tariff costs, margin compression, and guidance at the lower end of its range. The cash flow statement is telling a completely different story.
Procter & Gamble (NYSE:PG) appointed Shailesh Jejurikar as Chairman of the Board, succeeding Jon R. Moeller following his retirement after 38 years at the company. The board transition shifts leadership at the top of Procter & Gamble’s governance structure as Moeller steps down from his role as Executive Chairman. Investors are watching the handover closely, given the potential long term implications for company culture, operations, and board oversight. For readers tracking long term...
A $425,000 nest egg can generate wildly different monthly paychecks depending on where you put it, but chasing the biggest number often destroys the very asset you need to last through your 70s.
Replicating a Social Security check with dividends sounds straightforward until you realize the yield you chase determines whether your income grows, stalls, or quietly disappears over the next two decades.
Consumer sentiment is flashing recession warnings, yet three blue-chip dividend legends are quietly building cases for returns that would shock most defensive investors heading into 2027.
Chasing a $50,000 monthly dividend stream sounds like a math problem, but the yield you pick determines whether your portfolio funds four decades of freedom or quietly cannibalizes itself while the checks keep arriving.
P&G navigates $1B cost headwind while guiding 1-3% organic sales growth for fiscal 2027.
A $1.25 million nest egg can fund a very different retirement depending on one number: your withdrawal yield. The gap between a conservative dividend portfolio and an aggressive one swings your annual income by tens of thousands of dollars, but the safer-looking choice does not always win.
With the 10-year Treasury yield near 4.70%, dividend stocks face a real test of relevance, and only a handful of names have the streak length and earnings power to still make the cut right now.
NHTC, HCWC, and NAII sell into the growing nutrition and wellness space.
An 8% yield looks like a shortcut to $80,000 a year without selling a single share, but the brokerage account tells a different story than the headline number does.
Procter & Gamble stock rallies on $3.8 billion acquisition of Thorne. Here’s what the deal means for PG shares.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
